This patient with anti-LGI1 encephalitis showed a favorable response to the first-line immunotherapy with a combination of IVMP and PE; however, psychobehavioral symptoms relapsed one month after the initial treatment and five months from the onset. Here, LGI1 is linked to encephalitis.